Abuja Hospitals Confirm Antivenom Supplies After Tragedy

Nigeria's capital territory is turning tragedy into action after the preventable death of a young social media influencer revealed gaps in emergency snakebite treatment.

The Federal Capital Territory Administration (FCTA) has confirmed that all government hospitals in Abuja maintain full supplies of both polyvalent and multivalent antivenoms, stored under strict quality controls at a central medical facility. The announcement came after singer Ifunanya Nwangene died from a snakebite at Federal Medical Centre in Jabi, triggering widespread concerns about antivenom shortages.

Dr. Adedolapo Fasawe, the territory's health secretary, emphasized that the issue isn't supply but timing and protocol adherence. "All snakebites must be treated as venomous until proven otherwise," she stressed, urging residents to stay calm, immobilize the affected limb, and get to a hospital immediately without trying traditional remedies like cutting the wound or applying tourniquets.

The FCTA has invested significantly in emergency infrastructure over recent months, deploying 12 new ambulances and expanding intensive care capacities across the territory. Residents can now call dedicated emergency lines to ensure swift transport to qualified facilities.

The Ripple Effect

The tragedy has sparked a complete overhaul of how the capital handles snakebite emergencies. Dr. Fasawe announced that monitoring and enforcement of clinical protocols will be intensified, with healthcare facilities facing sanctions for negligence or failure to follow approved treatment standards.

The administration is also ramping up public education about snakebites as urban areas expand into natural habitats where cobras, vipers, and puff adders live. Veterinary doctors now collaborate with health officials to identify the most common snake species in the FCT, ensuring hospitals stock the right types of antivenom.

The medical stores managing the antivenom supplies use cold chain technology to maintain medication potency, guaranteeing that when emergencies strike, treatments work as intended. This centralized system allows health officials to track inventory and quality in real time.

While the hospital where Nwangene was treated noted she arrived with advanced neurotoxic symptoms hours after the bite, the case has pushed authorities to emphasize that early treatment dramatically improves survival chances. Antivenom works best within the first few hours after a bite, before venom reaches critical organs.

Dr. Fasawe expressed condolences to Nwangene's family while framing her death as a turning point that will save future lives through better awareness and accountability.